Chuck Peterson of Omaha, Nebraska, recently experienced a swollen, painful knuckle caused by arthritis. He got a prescription for colchicine. Doctors have used the drug for treating gout and other rheumatic conditions for well over two centuries. When Peterson went to the pharmacy, he was… Read More »The FDA Seeks a New Way to Review Old Drugs Without Causing Prices to Soar
Can’t see the audio player? Click here to listen on SoundCloud. Congress is out of session, but that hasn’t stopped Democrats from planning their next round of health legislation. Together with President Joe Biden, they are looking at a broad array of possibilities, from allowing Medicare… Read More »KHN’s ‘What the Health?’: Planning for Round Two
KHN has put together an interactive tool of significant health policies implemented by the Trump administration using its own authority — executive orders, agency guidance or formal regulations — and is tracking Biden administration and court actions. We will update this chart as actions are… Read More »The Great Undoing: Which of Trump’s Policies Will Biden Reverse?
Can’t see the audio player? Click here to listen on SoundCloud. As questions swirl about the covid vaccine made by AstraZeneca, public health experts are worried the confusion could create more doubts among people already hesitant to get a vaccine. Meanwhile, the first Senate-confirmed officials are… Read More »KHN’s ‘What the Health?’: Getting Down to Work at HHS
Democrats, newly in control of Congress and the White House, are united behind an idea that Republican lawmakers and major drugmakers fiercely oppose: empowering the Department of Health and Human Services to negotiate the prices of brand-name drugs covered by Medicare. This story also ran… Read More »Democrats Eye Medicare Negotiations to Lower Drug Prices
The Ohio attorney general has filed a lawsuit alleging that a Centene subsidiary, which provides Medicaid services in the state, hired multiple companies to administer pharmacy benefits in order to inflate costs. As a result, the state’s Medicaid department paid millions in overcharges.
Florida, Colorado and several New England states are moving ahead with efforts to import prescription drugs from Canada, a politically popular strategy greenlighted last year by President Donald Trump. But it’s unclear whether the Biden administration will proceed with Trump’s plan for states and the… Read More »States Move Ahead With Canada Drug Importation While Awaiting Signal From Biden
Remdesivir, Given to Half of Hospitalized Covid Patients in U.S., Is Big Win for Gilead — Boosted by Taxpayers
It was the end of April — just as the U.S. confirmed its millionth covid-19 case and 50,000 deaths — when White House adviser Dr. Anthony Fauci announced “highly significant” news about a drug called remdesivir. That was surprising because the antiviral drug, owned by… Read More »Remdesivir, Given to Half of Hospitalized Covid Patients in U.S., Is Big Win for Gilead — Boosted by Taxpayers
Joe Biden ran on an expansive health care platform during his 2020 presidential campaign, with a broad array of promises such as adding a government-sponsored health plan to the Affordable Care Act and lowering prescription drug prices. Perhaps most significantly, he pledged to get control… Read More »Health Issues Carried Weight on the Campaign Trail. What Could Biden Do in His First 100 Days?
Ante la pandemia, los demócratas han abogado por ayudas más generosas, más presión sobre las farmacéuticas para que bajen los precios y más atención al racismo sistémico en la atención de salud. El 20 de enero, con el control del Senado y la Cámara de… Read More »Aunque controlen el Senado, demócratas necesitarán apoyo republicano en temas clave de salud
Use Our Content It can be republished for free. Democrats have argued for more generous pandemic relief, more pressure on drugmakers to lower prices and more attention to systemic racism in health care. On Jan. 20, with control of the Senate and the House of… Read More »Even With Senate Control, Democrats Will Need Buy-In From GOP on Key Health Priorities
The party split in Congress is so slim that, even with Democrats technically in the majority, passing major health care legislation will be extremely difficult. So speculation about President-elect Joe Biden’s health agenda has focused on the things he can accomplish using executive authority. Although… Read More »Biden’s First Order of Business May Be to Undo Trump’s Policies, but It Won’t Be Easy
Ted Howard started taking Truvada a few years ago because he wanted to protect himself against HIV, the virus that causes AIDS. But the daily pill was so pricey he was seriously thinking about giving it up. Under his insurance plan, the former flight attendant… Read More »Many Health Plans Now Must Cover Full Cost of Expensive HIV Prevention Drugs
This story also ran on Fortune. It can be republished for free. Sharon Clark is able to get her life-sustaining cancer drug, Pomalyst — priced at more than $18,000 for a 28-day supply — only because of the generosity of patient assistance foundations. Clark, 57,… Read More »Seniors Face Crushing Drug Costs as Congress Stalls on Capping Medicare Out-Of-Pockets
Can’t see the audio player? Click here to listen on SoundCloud. COVID-19 was the dominant — but not the only — health policy story of 2020. In this special year-in-review episode of KHN’s “What the Health?” podcast, panelists look back at some of the biggest non-coronavirus… Read More »KHN’s ‘What the Health?’: 2020 in Review — It Wasn’t All COVID
Health insurance companies will have to give their customers estimated out-of-pocket costs for prescription drugs and disclose to the public the negotiated prices they pay for drugs, under an unexpected new Trump administration rule. The administration said those requirements, part of a broader rule issued… Read More »Surprise Federal Drug Rule Directs Insurers to Reveal What They Pay for Prescription Drugs
If they’ve been listening to President Donald Trump, seniors may be expecting a $200 debit card in the mail any day now to help them pay for prescription drugs. He promised as much this month, saying his administration soon will mail the drug cards to… Read More »A $200 Debit Card Won’t Do Much for Seniors’ Drug Costs
Florida’s plan to import cheaper prescription drugs from Canada — designed by Gov. Ron DeSantis and endorsed by President Donald Trump — has tasted its first bitter pill. No private firms bid on Florida’s $30 million contract to set up and operate a drug importation… Read More »Florida Fails to Attract Bidders for Canada Drug Importation Program
During the first presidential debate of 2020, President Donald Trump touted his efforts to curb skyrocketing drug prices and declared that insulin is now “so cheap, it’s like water.” The response on social media was swift, and divided, with some people sharing pharmacy… Read More »Progressive Group Highlights Trump, Tillis Weakness on Insulin Price Tags
DENVER — D.j. Mattern had her Type 1 diabetes under control until COVID’s economic upheaval cost her husband his hotel maintenance job and their health coverage. The 42-year-old Denver woman suddenly faced insulin’s exorbitant list price — anywhere from $125 to $450 per vial —… Read More »Not Pandemic-Proof: Insulin Copay Caps Fall Short, Fueling Underground Exchanges
For a dad whose infant son was afflicted with a rare seizure disorder, a drug invented in 1952 was indispensable for his boy. It was also indispensable to executives at the pharmaceutical firm that acquired the drug in 2014 — not because it was a… Read More »Old Drug Turned ‘Cash Cow’ as Company Pumped Price to $40K a Vial, Emails Show
President Donald Trump has long considered lowering the high cost of prescription drugs to be one of his signature issues, and it is likely to be a talking point he relies on throughout the upcoming campaign. During his afternoon speech Monday ― delivered on the… Read More »Trump Again Claims He’s Bringing Down Drug Prices, But Details of How Are Skimpy
Can’t see the audio player? Click here to listen on SoundCloud. President Donald Trump’s pivot to a more serious view of the coronavirus pandemic didn’t last long. This week, he was again touting hydroxychloroquine, an antimalarial drug that has not been shown to work against the… Read More »KHN’s ‘What The Health?’: Republicans in COVID Disarray
The post Can wastewater monitoring help inform future drug prevention strategies? appeared first on Healthy Debate.